ImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an ...

Within days, the patient started improving, and her bladder and bowel control slowly returned, along with sensations in both her legs.

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA ...

The FDA has authorized ImmunityBio’s expanded access program to bring alternative sources of the cancer-fighting bacteria BCG ...

Tuberculosis may seem like a disease of the past—more associated with Victorian waifs and overcrowded tenements than medicine in the 21st century—but it’s definitely still with us. Here’s ...

Kano State Commissioner for Health, Dr. Abubakar Yusuf Labaran, has raised concerns over the resurgence of leprosy in the ...

FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication.

The pCR was 37.3% (95% CI, 33.2-41.6) in the durvalumab arm and 27.5% (95% CI, 23.8-31.6) in the comparator arm.

The study, which tracked associations between erectile function, ... Tuberculosis Disease Intensifies HIV Antibody Response in People With HIV May 9, 2023 — New research found that people living ...

Feb. 7, 2024 — The drugs used to treat erectile dysfunction may also be associated with a reduced risk of Alzheimer's disease, according to new research. The study ...

James Headen Pfitzer, Senior Director, Global Policy, Corporate Affairs, Viatris and Melissa Mitchell, AMR IA Secretariat LeadOur world is rapidly changing, and policymakers face no ...